GlaxoSmithKline Pakistan Market Cap

GlaxoSmithKline Pakistan has a market cap or net worth of 125.52 billion as of December 5, 2025. Its market cap has increased by 22.69% in one year.

Market Cap

125.52B

Enterprise Value

118.88B

Revenue

62.07B

Ranking

n/a

PE Ratio

13.66

Stock Price

394.13

Market Cap Chart

Since September 26, 1994, GlaxoSmithKline Pakistan's market cap has increased from 3.77B to 125.52B, an increase of 3,228.63%. That is a compound annual growth rate of 11.88%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	125.52B	-0.70%
Dec 31, 2024	126.40B	378.26%
Dec 29, 2023	26.43B	-5.45%
Dec 30, 2022	27.95B	-35.70%
Dec 31, 2021	43.47B	-28.84%
Dec 31, 2020	61.09B	19.47%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Abbott Laboratories (Pakistan)	102.31B
The Searle Company	62.34B
Highnoon Laboratories	56.67B
AGP Limited	52.56B
Shifa International Hospitals	33.37B
Citi Pharma	20.49B
Ferozsons Laboratories	16.31B
Macter International	15.37B

Market Cap Rankings